ABPI responds to UK points-based immigration system
The ABPI has outlined how the new immigration system in the UK will affect life science workers and businesses, emphasising the need for regular reviews to remain competitive.
List view / Grid view
The ABPI has outlined how the new immigration system in the UK will affect life science workers and businesses, emphasising the need for regular reviews to remain competitive.
Boris Johnson, the Prime Minister of the UK, has announced a new Global Talent visa for researchers and scientists which will fast track those in certain fields.
Researchers have revealed that small- and medium-sized companies will by key in the growth of the life sciences sector in Scotland.
The government has issued a letter to the pharmaceutical industry, outlining how to prepare for a no-deal Brexit.
New permanent building to be completed by 15 November 2019...
The EMA Management Board have met in an extraordinary session to discuss EMA’s future premises in Amsterdam...
The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union...
Wayne Pines, President of Healthcare at APCO Worldwide in Washington DC and a former Associate Commissioner of the FDA believes Milan is a logical choice for the relocation of the EMA...
Researchers have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease.
17 November 2016 | By Pharma Parallel Trade
Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices...
20 June 2016 | By Caroline Richards, Editor, Drug Target Review
As Britons go to polling stations to vote in the EU Referendum, we can't help but wonder how you feel...